A new drug called momelotinib reduces the need for blood transfusions in anemic patients suffering from myelofibrosis.
Kevin Machel
Kevin studied biomedical chemistry in Mainz and has always been obsessed with how and why molecules do what they do. In particular, he's interested in using radioactive elements for medical purposes and how to overcome the challenges of cancer treatment.